Boris Gorelik
Förmögenhet: - $ per 2026-08-31
Förmögenhet: - $ per 2026-08-31
Boris Gorelik is currently VP-Business Development & Strategic Programs at Kamada Ltd. since 2022.
Formerly, Mr. Gorelik was Senior Director-Corporate Business Development at Teva Pharmaceutical Industries Ltd. and Chief Financial Officer at Nextgen Biomed Ltd. from 2016 to 2019.
Education includes undergraduate, graduate, and MBA degrees from Tel-Aviv University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
KAMADA LTD -.--% | 2026-04-07 | 0 ( -.--% ) | - $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| KAMADA LTD. | Företagsledare/Principal | 2020-04-01 |
| Företag | Position | Slut |
|---|---|---|
| NEXTGEN BIOMED LTD | Finansdirektör/CFO | 2019-07-31 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kamada Ltd.
Kamada Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and manufactures plasma-derived therapeutics products | Health Technology |
Nextgen Biomed Ltd.
Nextgen Biomed Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures skin diseases pharmaceutical products | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån